Kellanova (K) stock has been catching some attention lately, as investors look beyond day-to-day moves to assess its strategic direction and broader performance. With steady revenue and net income growth reported, the company is maintaining momentum in a competitive market.
See our latest analysis for Kellanova.
Kellanova’s share price has climbed 5.2% in the past three months, reflecting renewed optimism as the company continues to post steady results amid industry competition. With a 5.8% total shareholder return over the past year and a cumulative five-year total return of 68.3%, momentum appears to be building as investors focus on its long-term story.
If you’re on the lookout for what else might offer solid upside, now could be a great time to broaden your search and discover fast growing stocks with high insider ownership
With the stock posting consistent gains yet trading right around analyst targets, the big question now is whether Kellanova is undervalued with room to run, or if the market is already pricing in its future growth.
With Kellanova’s share price closing at $83.64 and the widely followed narrative fair value target set at $83.39, investors are seeing a close alignment between current market sentiment and projected earnings potential. This minimal difference signals that the latest company outlook is largely priced in, but it is worth examining what is driving this consensus.
The company’s focus on differentiated geographic footprint, particularly in emerging markets, should lead to sequential volume improvement and organic growth in net sales, positively impacting revenue. A heavy calendar of innovation, including product launches in snacks and away-from-home channels, is projected to increase net sales contribution from innovation, driving revenue growth.
Read the complete narrative.
Curious what kind of earnings growth and profit margins are backing this fair value? The narrative relies on a blueprint of aggressive innovation, bold new launches, and ambitious performance metrics. Want to see which numbers the valuation hinges on? Uncover the details that the market is watching closely.
Result: Fair Value of $83.39 (ABOUT RIGHT)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, shifts in consumer spending in Europe or innovation setbacks in major product launches could challenge Kellanova’s steady growth outlook.
Find out about the key risks to this Kellanova narrative.
While the consensus price target suggests Kellanova is fairly valued, our DCF model estimates the company’s fair value at $95.81. This is 12.7% above the current share price. This method implies the market might be overlooking potential upside. Could the real value be higher than expected?
Look into how the SWS DCF model arrives at its fair value.
K Discounted Cash Flow as at Nov 2025
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Kellanova for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 920 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.
If you think the story could unfold differently or want to review the numbers firsthand, you can craft your own perspective in just minutes. Do it your way
A great starting point for your Kellanova research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
Don’t let opportunity slip away. Expand your horizons now and take advantage of exclusive stock ideas the market hasn’t fully noticed yet with the Simply Wall Street Screener.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include K.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Privia Health Group has seen its Fair Value Estimate increase slightly to $31.11 from $30.89. This signals modest analyst optimism based on recent company updates. Revenue growth projections have also edged higher, now expected to reach 12.04%. Stay tuned to discover how investors and followers can monitor future shifts in Privia Health Group’s evolving story.
Analyst Price Targets don’t always capture the full story. Head over to our Company Report to find new ways to value Privia Health Group.
🐂 Bullish Takeaways
At this time, there is limited specific analyst commentary available to support strongly bullish sentiment for Privia Health Group.
Analysts are generally positive on factors such as the company’s solid execution, consistent revenue growth, and ongoing transparency in reporting.
Near-term growth momentum continues to be viewed as a favorable aspect, and there is ongoing attention to cost control and scalability.
🐻 Bearish Takeaways
Some cautious perspectives remain around valuation concerns and whether the recent upside is already priced in.
Mixed analyst sentiment includes reservations about near-term risks that could impact future performance. However, no substantial price target changes from major firms have been highlighted in recent commentary.
Overall, while the coverage is modest at present, analysts appear to be weighing Privia Health Group’s solid growth against its current valuation and market expectations. This leaves room for both optimism and caution as the story continues to unfold.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!
NasdaqGS:PRVA Community Fair Values as at Nov 2025
Privia Health Group, Inc. has raised its full-year 2025 earnings guidance and now expects GAAP revenue to be between $2,050 million and $2,100 million. This is an increase from the previous estimate of $1,800 million to $1,900 million.
The latest financial update reflects increased confidence in the company’s ability to deliver robust revenue growth in the coming year.
This updated guidance highlights the company’s recent operational and strategic momentum, providing investors with improved visibility into Privia Health Group’s future prospects.
The Fair Value Estimate has risen slightly to $31.11 from $30.89, reflecting modest analyst optimism.
The Discount Rate remains effectively unchanged at 6.96%.
Revenue Growth has improved marginally and is now projected at 12.04%, up from 11.99%.
The Net Profit Margin has fallen significantly to 2.84%, compared to the previous estimate of 3.48%.
The Future P/E Ratio has increased notably to 60.57x from 50.02x, indicating higher expected valuations relative to earnings projections.
Narratives are a powerful tool that let investors share their story behind the numbers. They link financial forecasts and fair value to a company’s bigger picture. On Simply Wall St, millions of users can access these dynamic Narratives on the Community page. Narratives make it easy to track when a stock is undervalued or overvalued and are automatically updated whenever fresh news or earnings are released, helping you decide the right time to buy or sell.
Read the original Narrative on Privia Health Group to see why it’s worth following:
Learn how demographic shifts, expansion into new markets, and a push towards value-based care are driving robust, long-term growth for Privia Health Group.
Understand how technology investments and a diversified contract portfolio are enhancing margins, operational efficiency, and earnings stability, even as the healthcare landscape evolves.
Stay ahead of both the upside potential and key risks such as rising costs, regulatory change, and competition by seeing how new data and market developments shape the story over time.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include PRVA.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Luxair, the flag carrier of Luxembourg, has welcomed the E195-E2 into its fleet – marking the start of an exciting new chapter as the airline pursues its ambition to modernize and grow sustainably.
Connecting Luxembourg with Europe and beyond, Luxair ensures mobility and accessibility at the heart of Europe. Deeply rooted in local communities, the airline is now set to elevate its customers’ travel experience. Passengers can look forward to spacious 2+2 seating, a generous pitch, a quiet cabin, as well as advanced in-flight entertainment.
Investors are often guided by the idea of discovering ‘the next big thing’, even if that means buying ‘story stocks’ without any revenue, let alone profit. But as Peter Lynch said in One Up On Wall Street, ‘Long shots almost never pay off.’ A loss-making company is yet to prove itself with profit, and eventually the inflow of external capital may dry up.
If this kind of company isn’t your style, you like companies that generate revenue, and even earn profits, then you may well be interested in Xylem (NYSE:XYL). Now this is not to say that the company presents the best investment opportunity around, but profitability is a key component to success in business.
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
The market is a voting machine in the short term, but a weighing machine in the long term, so you’d expect share price to follow earnings per share (EPS) outcomes eventually. Therefore, there are plenty of investors who like to buy shares in companies that are growing EPS. It certainly is nice to see that Xylem has managed to grow EPS by 30% per year over three years. As a general rule, we’d say that if a company can keep up that sort of growth, shareholders will be beaming.
One way to double-check a company’s growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. While we note Xylem achieved similar EBIT margins to last year, revenue grew by a solid 5.6% to US$8.9b. That’s encouraging news for the company!
You can take a look at the company’s revenue and earnings growth trend, in the chart below. Click on the chart to see the exact numbers.
NYSE:XYL Earnings and Revenue History November 29th 2025
View our latest analysis for Xylem
The trick, as an investor, is to find companies that are going to perform well in the future, not just in the past. While crystal balls don’t exist, you can check our visualization of consensus analyst forecasts for Xylem’s future EPS 100% free.
We would not expect to see insiders owning a large percentage of a US$34b company like Xylem. But we are reassured by the fact they have invested in the company. We note that their impressive stake in the company is worth US$194m. This comes in at 0.6% of shares in the company, which is a fair amount of a business of this size. This still shows shareholders there is a degree of alignment between management and themselves.
While it’s always good to see some strong conviction in the company from insiders through heavy investment, it’s also important for shareholders to ask if management compensation policies are reasonable. Well, based on the CEO pay, you’d argue that they are indeed. Our analysis has discovered that the median total compensation for the CEOs of companies like Xylem, with market caps over US$8.0b, is about US$13m.
The Xylem CEO received US$11m in compensation for the year ending December 2024. That is actually below the median for CEO’s of similarly sized companies. CEO compensation is hardly the most important aspect of a company to consider, but when it’s reasonable, that gives a little more confidence that leadership are looking out for shareholder interests. It can also be a sign of good governance, more generally.
If you believe that share price follows earnings per share you should definitely be delving further into Xylem’s strong EPS growth. If you still have your doubts, remember too that company insiders have a considerable investment aligning themselves with the shareholders and CEO pay is quite modest compared to similarly sized companiess. Everyone has their own preferences when it comes to investing but it definitely makes Xylem look rather interesting indeed. It is worth noting though that we have found 1 warning sign for Xylem that you need to take into consideration.
Although Xylem certainly looks good, it may appeal to more investors if insiders were buying up shares. If you like to see companies with more skin in the game, then check out this handpicked selection of companies that not only boast of strong growth but have strong insider backing.
Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.
Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Wall Street thinks you don’t own enough stock. Not “you,” specifically, but investors as a collective are viewed as too lightly exposed to equities given the S & P 500 is three years into a bull market and is back to within 1% of its all-time peak from a month ago. Deutsche Bank’s comprehensive investor positioning gauge is hovering around neutral. John Flood, head of Americas equities sales trading at Goldman Sachs, says: “Our sentiment indicator has spent most of the year in negative territory reflecting relatively conservative institutional investor positioning. The wall of worry has been extremely high this year and remains omnipresent (this is a bullish signal).” The reason to note such assessments is that we’ve entered the season when “flow-of-funds” trends and the mechanical maneuvering of investors toward a final scorecard for the year tend to form the core of the bulls’ argument. Essentially all earnings for 2025 are in the books. Recent Federal Reserve messaging has restored expectations of a rate cut on Dec. 10. Business-news flow is set to slow down as holidays encroach. Which leaves market handicappers trying to sort out how much latent buying power remains among investors. Through this lens, the S & P 500′s first 5% setback in seven months, culminating a week ago Friday, was a big help in shaking out anxious investors, resetting investor sentiment and testing the key fundamental premises that have animated the bull market. Was that all that was needed to refresh a market uptrend that had grown pretty overheated with speculative momentum, complacency about the macroeconomic picture and low-quality-stock leadership into late October? Warren Pies, founder of 3Fourteen Research, last week upgraded equities to an overweight in part because he believes the answer to that question is “Yes.” He noted that into the third week of November, volume in “inverse” ETFs – those that profit from falling stock prices – surged above 40% of total volume in both inverse and leveraged-long ETFs. This has only happened four times in the past couple of years, each one coinciding with a forceful rally near a tactical bottom in the indexes. Among other things, this suggests that retail traders as a group did not lead the way in buying the November dip and driving the five-day, nearly 5% sprint higher in the S & P 500 through Friday, which turned a 4.5% intra-month loss to a small gain for November. .SPX 1M mountain SPX 1-month chart (Most likely the nasty tailspin in bitcoin from $124,000 to around $80,000 at its recent low, left retail portfolios in no position to add more risk aggressively. Bitcoin correlates more closely with shares of unprofitable tech companies than with any macro indicator or other asset market.) Along with sharp retrenchments by hedge funds that use systematic strategies based on volatility and momentum, the crescendo of interest in inverse ETFs prompted Pies to call for further upside from here: “Three big buckets of investors— retail, vol-target funds, and CTAs— derisked during the selloff. On the other side of the ledger, corporations are gearing up to buy the market into year-end” by flexing their share-repurchase budgets. This kind of seasonal reasoning and supply-versus-demand case for expecting a further rally makes sense at the essential level, where prices are purely a function of the relative urgency of buyers and sellers. Still, on a more structural level, U.S. equity allocations by private investors have rarely been higher, based on data from Bank of America’s private-client group, the Federal Reserve and other sources. And keep in mind that we heard similar talk of a “year-end chase higher” a year ago as the S & P 500 emerged from a similar pullback in late November. Yet that late-2024 comeback rally peaked a week into December before a sloppy three-week retreat into the close of that year. Those disclaimers aside, the tape action itself has been reassuring and largely in keeping with how stocks have behaved in the months following 15%-or-greater corrections such as the S & P 500 suffered from February into April. Strategas Research plotted the current recovery path against the average and median recovery trajectories from all prior such setbacks. Note the 2025 performance is better than the norm, though typically around this point the advance at least starts to flatten out. Reviewing the sturdy finish to November this year after a three-week gut check, Tony Pasquariello, head of hedge fund coverage at Goldman Sachs, observed that “given the starting point of some scorching rallies in October, and, for as high-velocity as November was, the fact that S & P finished this month in the green is notable.” To go a step more granular, the S & P 500 proved resilient in a month when Nvidia fell 12.5%, something not many would likely have predicted four weeks ago. It’s as if the market heard the constant complaints that its run to a record high looked “too narrow” and too focused on the same AI winners and responded by coming back from a three-week stress test with a series of very broad rally days not led by the usual “Magnificent Seven” favorites. That said, the amount of market cap being accumulated and disgorged daily by the massive tech platform companies isn’t entirely comforting. The market’s attempt to discern relative winners and losers, rather than indiscriminately reward every company involved, is an admirable, necessary exercise. But Alphabet going from “AI victim” to “presumed winner” while adding nearly $2 trillion in market capitalization over seven months’ time might also reflect an erratic mixture of fickleness, desperation and herding among investors. The Street’s official play callers appear unconcerned by such extreme mood swings, or by much of anything, as they project ahead into next year. About a dozen Wall Street strategists have set their end-of-2026 S & P 500 targets. All of them see at least some further upside, with the median target of 7,500 and the average near 7,580 bracketing a 10% climb from Friday’s closing level. Not wildly optimistic, especially given consensus forecasts for around 13% S & P 500 earnings growth next year. But as these things go, a 10% collective projection qualifies as rather upbeat – the average strategist target has been at or below the index level most of this year. And, as the past few weeks have shown, attitudes have a way of overshooting and eventually throwing investors off-balance, even in what’s generally been a sure-footed bull market.
Wondering if Eni’s recent run puts the stock at a discount or if the best value days are already behind it? You’re not alone, as investors everywhere are asking the same question right now.
Eni’s share price has climbed 19.8% so far this year and 29.1% over the past 12 months, indicating renewed optimism and possible growth ahead.
Much of this excitement has been fueled by recent positive developments in the energy sector, including moves toward cleaner production and new international projects. News highlighting Eni’s investment in low-carbon initiatives and overseas exploration has caught investors’ attention and contributed to the stock’s upward momentum.
On the valuation front, Eni scores a 3 out of 6 based on our undervaluation checks. Next, we will explore the methods behind that score and provide insights to help better understand Eni’s real value.
Eni delivered 29.1% returns over the last year. See how this stacks up to the rest of the Oil and Gas industry.
The Discounted Cash Flow (DCF) model estimates a company’s value by projecting its future cash flows and discounting them back to today’s value. This approach helps investors gauge the present worth of all expected future cash the business will generate, using current financial data and reasonable growth assumptions.
For Eni, the most recent Free Cash Flow stands at approximately €4.40 billion. According to analyst consensus and Simply Wall St extrapolations, these cash flows are forecast to grow moderately, with projections reaching roughly €5.19 billion by 2028 and continuing upwards through 2035. Early estimates rely on analyst forecasts, while later years use logical estimates based on prevailing growth trends in the sector.
Using these inputs, the DCF analysis values Eni at an intrinsic fair value of €22.02 per share. This suggests that the current market price is about 26.7 percent below what the company’s future cash flows are worth today, indicating the stock is significantly undervalued according to this model. For investors seeking growth and value, this assessment may indicate a promising entry point.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Eni is undervalued by 26.7%. Track this in your watchlist or portfolio, or discover 920 more undervalued stocks based on cash flows.
ENI Discounted Cash Flow as at Nov 2025
Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Eni.
The Price-to-Earnings (PE) ratio is a well-known method used to value profitable companies like Eni, as it connects the market price to the company’s actual earnings. This metric is especially relevant for established businesses with positive earnings, offering a straightforward way to compare value across the sector.
It’s important to remember that what counts as a “normal” or “fair” PE ratio can change depending on growth prospects and perceived risk. Companies expected to grow rapidly or those considered safer investments typically command higher PE ratios, while riskier or slower-growing firms usually see lower multiples.
Currently, Eni trades at a PE ratio of 18.7x, which is higher than both the industry average of 13.3x and the peer group average of 13.1x. At first glance, this might suggest Eni is more expensive than its rivals. However, simply comparing these averages does not tell the whole story. This is where Simply Wall St’s “Fair Ratio” comes in. The Fair Ratio, calculated at 21.5x for Eni, incorporates not just earnings but also factors like Eni’s growth outlook, profitability, risk profile, industry position, and its size in the market.
The Fair Ratio is a more holistic metric than industry or peer comparisons because it is tuned to Eni’s specific fundamentals, rather than being based on broader or less relevant companies. In this case, Eni’s actual PE ratio is about 2.8x below its Fair Ratio, indicating that, on this measure, the stock could be considered undervalued.
Result: UNDERVALUED
BIT:ENI PE Ratio as at Nov 2025
PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1443 companies where insiders are betting big on explosive growth.
Earlier we mentioned that there is an even better way to understand valuation, so let’s introduce you to Narratives. A Narrative is your own story about a company that connects what you believe about its business, industry changes, and trends with the actual numbers, such as fair value, future revenue, earnings, and profit margins.
Rather than simply relying on historic data or a single metric, Narratives let you link what is happening in the real world to a financial forecast and, ultimately, to what you believe is a fair price for the stock. This approach is accessible and easy to use for investors of all experience levels on Simply Wall St, right from the Community page used by millions.
Narratives empower you to decide when to buy or sell, making it simple to see at a glance how your fair value compares to the current price. Because they update automatically with new information, such as news, earnings reports, or industry developments, your view is always relevant and up to date.
For example, when it comes to Eni, some investors are optimistic and see a fair value as high as €17.5, while others, more cautious, estimate just €13.5. This illustrates how Narratives capture the range of real investor perspectives and make stock decisions more intuitive and personal.
Do you think there’s more to the story for Eni? Head over to our Community to see what others are saying!
BIT:ENI Community Fair Values as at Nov 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ENI.MI.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Texas Instruments’ price target remains steady, reflecting confidence in the company’s long-term fundamentals despite shifting economic conditions. Analyst sentiment incorporates a mix of optimism around disciplined inventory management as well as cautiousness due to margin pressures and muted growth visibility. Stay tuned to see how you can monitor ongoing updates to the Texas Instruments investment narrative.
Analyst Price Targets don’t always capture the full story. Head over to our Company Report to find new ways to value Texas Instruments.
Recent analyst commentary on Texas Instruments reflects a diverse range of perspectives on the company’s current positioning and outlook. Below, we synthesize the main themes from the latest research updates.
🐂 Bullish Takeaways
Rosenblatt maintains a Buy rating for Texas Instruments, noting disciplined management even in the face of operational headwinds. Despite lowering the price target to $200 from $245, the firm points to inline results and confident handling of inventory and manufacturing assets as strengths.
JPMorgan keeps an Overweight rating and adjusted its price target to $210 from $225, citing solid September quarter revenue and a continued belief in Texas Instruments’ long-term positioning. The “conservative” forward outlook is seen as a prudent response to macro uncertainty rather than a signal of execution issues.
Wolfe Research remains constructive, reiterating an Outperform rating with a $230 price target. The firm recognizes that recoveries are underway in most major end markets, with the exception of automotive, and sees prudent inventory and wafer start management as indicative of operational discipline.
Morgan Stanley suggests potential upside if low customer inventories drive replenishment, even as it takes a more reserved view overall. The firm acknowledges the flat recovery slope but points to eventual positive momentum as order trends improve.
🐻 Bearish Takeaways
Mizuho downgraded Texas Instruments to Underperform, dropping the price target significantly to $150 from $200. The analyst raises concerns about the lack of near-term catalysts, premium valuation, slowing auto sales, ongoing competition in China, and tariff headwinds. Additionally, the company’s smaller footprint in high-growth segments like AI data centers is seen as a limitation.
Truist lowered its price target to $175 from $196 while maintaining a Hold rating, citing mixed quarterly results and fading margins. The analyst notes that while inventory levels have normalized, demand has not rebounded, and customers are not actively restocking, which limits prospects for near-term recovery.
Rosenblatt, while positive overall, highlights that margin pressures linked to reduced fab utilization are likely to persist in the short term as management seeks to balance inventory levels.
Morgan Stanley keeps an Underweight rating with a reduced target of $192 from $197, expressing caution over the underwhelming outlook for the September quarter and the challenging recovery trajectory presently facing the analog semiconductor sector, of which Texas Instruments is a key part.
Together, these perspectives underscore a broad consensus that Texas Instruments remains well-managed but faces ongoing challenges tied to margins, sector cycles, and macroeconomic headwinds. Bullish analysts reward the company’s execution and prudent financial management, while the more bearish voices warn that upside may be constrained until clearer growth catalysts emerge and pressures on margins begin to ease.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!
NasdaqGS:TXN Community Fair Values as at Nov 2025
U.S. officials are considering a delay to the planned 100% tariffs on imported semiconductors. This move would impact major manufacturers like Texas Instruments as policymakers weigh a more cautious approach to economic relations with China.
China is experiencing significant semiconductor shortages due to America’s chip export restrictions. In response, Chinese authorities are taking a more active role in managing the supply of critical chips and are prioritizing access for domestic companies.
Beijing has suspended export restrictions for one year on five key minerals essential to semiconductor manufacturing, including gallium and germanium. This decision has the potential to shift dynamics in the global supply chain.
The Chinese government now requires that state-funded data centers use only domestically produced AI chips and is moving to replace foreign chips in ongoing projects. This policy could affect international chipmakers such as Texas Instruments.
Fair Value: Unchanged at $189.56 per share, reflecting stable long-term outlook assumptions.
Discount Rate: Decreased slightly from 10.92% to 10.81%. This indicates a marginally lower perceived risk in future cash flows.
Revenue Growth: Remains stable at 9.43% per year with no significant change in growth expectations.
Net Profit Margin: Increased modestly from 33.85% to 33.86%, indicating a very minor improvement in profitability forecasts.
Future P/E: Increased slightly from 30.29x to 30.40x, suggesting a marginally higher valuation multiple placed on future earnings.
A Narrative is more than just numbers; it’s the story behind a company’s value. On Simply Wall St, Narratives let investors like you link a company’s unique business outlook to a forecast and a fair value, making complex investing simple. Narratives help you decide when to buy or sell by comparing fair value with today’s price, and they are always kept up to date as new data or news breaks.
See the latest insights and follow the original Texas Instruments Narrative to understand:
How disciplined inventory management and the possible delay of tariffs could support a modest recovery in revenue and margins.
Why investments in U.S. manufacturing and tax incentives could strengthen supply chains and drive long-term earnings growth despite industry risks.
The balance of bullish expectations for industrial and automotive chip demand, alongside competitive and geopolitical challenges that could impact future performance.
Read the full Texas Instruments Narrative on Simply Wall St’s Community: TXN: Inventory Discipline And Tariff Delay Will Support Modest Recovery Ahead
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TXN.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
The consensus analyst price target for Lundin Gold has risen slightly from CA$92.17 to CA$93.42, highlighting modestly increased expectations for the company’s fair value. This change comes amid more optimistic forecasts for gold and silver prices, and it reflects recent analyst reassessments of the sector. Stay tuned to find out how investors and analysts can keep informed about the evolving outlook for Lundin Gold.
Analyst Price Targets don’t always capture the full story. Head over to our Company Report to find new ways to value Lundin Gold.
🐂 Bullish Takeaways
BMO Capital increased its price target for Lundin Gold to C$104 from C$93 and maintained a Market Perform rating. This price target revision signals recognition of recent operational execution and market performance.
CIBC made a more substantial adjustment by raising its price target to C$116 from C$85. This reflects higher future gold and silver price forecasts, with CIBC now projecting gold at $4,500 per ounce and silver at $55 per ounce in 2026 and 2027.
These target increases are largely attributed to industry-wide updates in commodity price outlooks, rewarding Lundin Gold’s year-to-date stock outperformance and ongoing resilience in cost management.
🐻 Bearish Takeaways
Despite the revised, more aggressive price targets, both CIBC and BMO Capital have maintained neutral stances (Neutral and Market Perform ratings, respectively). This indicates that some analysts believe current valuation already reflects much of the near-term upside.
CIBC notes that recent recommended price changes are in part a “catch-up” to reflect recent gold price movements, rather than a fundamental shift in expectations for the company’s execution or intrinsic value.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!
TSX:LUG Community Fair Values as at Nov 2025
Lundin Gold reported strong results from exploration drilling at Fruta del Norte, making progress toward an initial Mineral Reserve estimate expected in early 2026. The company also achieved Reserve replacement in both 2023 and 2024, highlighting ongoing resource growth.
Positive drilling outcomes were announced at the Sandia, Trancaloma, and Castillo targets, with the discovery of new high-grade mineralized zones and further expansion potential in all directions.
For the third quarter and year-to-date 2025, Lundin Gold posted higher ore processing and gold recovery rates. Despite these improvements, the average head grade and doré output were slightly lower compared to the previous year.
A leadership change was announced. Ron Hochstein will step down as President, CEO and Director, with Jamie Beck appointed as new CEO effective November 7, 2025.
The consensus analyst price target has risen slightly from CA$92.17 to CA$93.42, reflecting a modest increase in perceived fair value.
The discount rate increased marginally from 7.04% to 7.06%, indicating a small upward adjustment to the risk premium applied.
The revenue growth estimate has increased significantly from 8.72% to 13.18%, pointing to higher expected topline expansion.
The net profit margin is projected to improve from 39.0% to 48.4%, showing increased profitability expectations.
The future price to earnings (P/E) ratio is projected to decline from 26.55x to 17.77x, suggesting anticipated earnings growth or a change in valuation approach.
A Narrative is a smarter, story-driven way to invest. It gives you not just the numbers, but the reasons behind them. Narratives link a company’s business story to its forecasted revenue, profit, and fair value, making it easy to track if a stock is priced attractively. On Simply Wall St’s Community page, millions of investors use dynamic Narratives to spot opportunities, react quickly as news emerges, and decide when value and price are aligned or out of sync.
Follow the original Lundin Gold Narrative here to stay in the loop on:
How rising and volatile gold prices could both boost and limit Lundin Gold’s future upside, exposing earnings to swings as analyst conviction changes
Developments in Lundin Gold’s resource expansion, exploration success, and their critical impact on mine life and long-term value
The risks and opportunities from operational efficiency, ESG leadership, and the company’s unique position as a single-asset miner in Ecuador
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include LUG.TO.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Curious whether Deutsche Bank’s stock is still good value after its recent rally? Let’s break down what seasoned investors need to know.
The stock has soared an eye-catching 95.7% over the last year and is up 82.1% year-to-date, though it dipped slightly by 1.5% over the past month.
Much of this momentum has been fueled by renewed optimism around the banking sector, as well as Deutsche Bank’s ongoing restructuring efforts. These efforts have garnered positive media attention and investor confidence worldwide.
For those focused on fundamentals, Deutsche Bank scores a 4 out of 6 on our valuation checks. This is a solid signal, but let’s dig deeper into traditional valuation approaches before revealing an even more insightful way to assess whether the stock is a bargain.
Deutsche Bank delivered 95.7% returns over the last year. See how this stacks up to the rest of the Capital Markets industry.
The Excess Returns valuation model helps investors assess whether a company is creating value above its cost of capital by comparing its return on equity to the required return. This approach focuses on both the efficiency of Deutsche Bank’s investments and its future growth prospects, rather than just current earnings or cash flows.
Deutsche Bank’s Book Value stands at €40.49 per share, while its Stable EPS is projected at €3.61 per share, based on weighted return on equity estimates from 11 analysts. The bank’s Cost of Equity is €3.78 per share, resulting in a small negative Excess Return of €-0.17 per share. With an average return on equity of 9.52%, the company’s ability to generate returns just trails the required rate, and the Stable Book Value is forecast to be €37.88 per share according to 7 analyst projections.
Using the Excess Returns method, Deutsche Bank’s intrinsic value implies the stock is currently 14.6% undervalued compared to its market price. This suggests the market may not yet be fully appreciating Deutsche Bank’s efforts to improve its earnings and capital efficiency.
Result: UNDERVALUED
Our Excess Returns analysis suggests Deutsche Bank is undervalued by 14.6%. Track this in your watchlist or portfolio, or discover 920 more undervalued stocks based on cash flows.
DBK Discounted Cash Flow as at Nov 2025
Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Deutsche Bank.
The Price-to-Earnings (P/E) ratio is widely considered a key tool for valuing profitable companies like Deutsche Bank, as it directly reflects how much investors are willing to pay for each euro of earnings. For established banks with steady profits, the P/E ratio can quickly indicate whether the stock price is in line with its financial performance.
What makes a “normal” P/E ratio? It is shaped by the company’s expected earnings growth, its profit stability, and the level of risk investors perceive in the business and industry. Fast-growing, lower-risk companies generally command higher P/E multiples, while mature or riskier firms often trade at lower levels.
Deutsche Bank currently trades at a P/E of 11.3x. This is below the Capital Markets industry average of 14.7x and also sits under the peer average of 17.8x. However, there is a more tailored benchmark to consider: the Simply Wall St Fair Ratio. For Deutsche Bank, the Fair Ratio is estimated at 26.5x, a proprietary metric that blends the company’s earnings outlook, profit margins, industry positioning, market capitalization, and risk factors. The Fair Ratio provides a more nuanced context than peers or industry averages alone because it takes into account how Deutsche Bank’s unique mix of strengths and risks affect its intrinsic value.
When comparing Deutsche Bank’s actual P/E of 11.3x to its Fair Ratio of 26.5x, the stock appears significantly undervalued, suggesting that the current price does not fully reflect the bank’s improved earnings prospects and position within its sector.
Result: UNDERVALUED
XTRA:DBK PE Ratio as at Nov 2025
PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1443 companies where insiders are betting big on explosive growth.
Earlier we mentioned that there is an even better way to understand valuation, so let’s introduce you to Narratives.
A Narrative is simply your story behind the numbers, an investor’s personal perspective on a company’s future that connects what you believe will happen next with a specific financial forecast and a fair value estimate. Narratives make investing more approachable because they link Deutsche Bank’s unique business drivers, key risks, and competitive advantages directly to concrete figures such as projected earnings, revenues, profit margins, and assumed valuation multiples. This approach helps transform complex financials into a story you can take action on.
This tool, available to millions of users on Simply Wall St’s Community page, empowers you to create, adjust, and follow Narratives that reflect your own views or those of other investors. By continuously updating with the latest earnings, news, and company events, Narratives allow you to compare your estimated fair value with Deutsche Bank’s current share price and decide when you think it is time to buy, hold, or sell.
For example, some investors’ Narratives assume Deutsche Bank will trade at €35.00 per share thanks to strong earnings and revenue growth. Others build a more cautious scenario with a fair value of just €10.93, reflecting higher risk or slower profit improvement.
Do you think there’s more to the story for Deutsche Bank? Head over to our Community to see what others are saying!
XTRA:DBK Community Fair Values as at Nov 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include DBK.DE.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
